BioVie Inc. Public Float
BioVie Inc. (BIVI) had Public Float of $8.45 million as of 2025-12-31, per its 10-K filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-08-13
- 2025-12-31: Entity Public Float $8.45M.
- 2024-12-31: Entity Public Float $32.01M.
- 2023-06-30: Entity Public Float $20.59M.
- 2022-12-31: Entity Public Float $86.03M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-12-31 | $8.45M 10-K · filed 2026-08-13 | |
| 2024-12-31 | $32.01M 10-K · filed 2025-08-15 | |
| 2023-06-30 | $20.59M 10-K · filed 2024-09-30 | |
| 2022-12-31 | $86.03M 10-K · filed 2023-08-16 | |
| 2021-12-31 | $23.35M 10-K · filed 2022-09-27 | |
| 2020-12-31 | $18.14M 10-K · filed 2021-08-30 | |
| 2020-06-30 | $18.14M 10-K/A · filed 2020-08-07 | |
| 2019-06-30 | $53.27M 10-K · filed 2019-09-27 | |
| 2018-09-28 | $315.05M 10-K · filed 2018-10-05 | |
| 2017-06-30 | $26.66M 10-K · filed 2017-08-24 | |
| 2016-06-30 | $31.38M 10-K · filed 2016-09-28 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $0.00 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $8.71M 10-K · filed 2015-10-01 | $0.00 10-Q · filed 2015-02-05 |
| 2013-12-31 | $8.71M 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |